These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15670977)

  • 1. CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.
    Trauzold A; Röder C; Sipos B; Karsten K; Arlt A; Jiang P; Martin-Subero JI; Siegmund D; Müerköster S; Pagerols-Raluy L; Siebert R; Wajant H; Kalthoff H
    FASEB J; 2005 Apr; 19(6):620-2. PubMed ID: 15670977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.
    Trauzold A; Wermann H; Arlt A; Schütze S; Schäfer H; Oestern S; Röder C; Ungefroren H; Lampe E; Heinrich M; Walczak H; Kalthoff H
    Oncogene; 2001 Jul; 20(31):4258-69. PubMed ID: 11464292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
    Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
    Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
    Hinz S; Trauzold A; Boenicke L; Sandberg C; Beckmann S; Bayer E; Walczak H; Kalthoff H; Ungefroren H
    Oncogene; 2000 Nov; 19(48):5477-86. PubMed ID: 11114725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1alpha enhances IL-8 secretion through p38 mitogen-activated protein kinase and reactive oxygen species signaling in human pancreatic cancer cells.
    Sawai H; Funahashi H; Okada Y; Matsuo Y; Sakamoto M; Yamamoto M; Takeyama H; Manabe T
    Med Sci Monit; 2005 Oct; 11(10):BR343-50. PubMed ID: 16192891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidermal growth factor-mediated NF-kappaB activation promotes uPA expression and invasiveness in pancreatic cancer cells].
    Zhang H; Liu XF; Li YJ; Zhou JP; Kong FM; Dong M
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):909-12. PubMed ID: 18478929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells.
    Siegmund D; Klose S; Zhou D; Baumann B; Röder C; Kalthoff H; Wajant H; Trauzold A
    Cell Signal; 2007 Jun; 19(6):1172-84. PubMed ID: 17291719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells.
    Zhou DH; Yang LN; Roder C; Kalthoff H; Trauzold A
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):94-8. PubMed ID: 23392805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA.
    Wang W; Abbruzzese JL; Evans DB; Chiao PJ
    Oncogene; 1999 Aug; 18(32):4554-63. PubMed ID: 10467400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.
    Nielsen A; Scarlett CJ; Samra JS; Gill A; Li Y; Allen BJ; Smith RC
    J Gastroenterol Hepatol; 2005 Feb; 20(2):256-63. PubMed ID: 15683429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
    Fujisawa T; Joshi B; Nakajima A; Puri RK
    Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
    Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma.
    Röder C; Trauzold A; Kalthoff H
    Eur J Cell Biol; 2011; 90(6-7):450-5. PubMed ID: 21129814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning of rock bream's (Oplegnathus fasciatus) tumor necrosis factor receptor-associated factor 2 and its role in NF-κB activiation.
    Kim WL; Kim MS; Kim KH
    Fish Shellfish Immunol; 2011; 30(4-5):1178-83. PubMed ID: 21320605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
    Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
    J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
    Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
    Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell.
    Zhou DH; Trauzold A; Röder C; Pan G; Zheng C; Kalthoff H
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):201-9. PubMed ID: 18397859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.